Search Within

Heiko Schoder

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (39)
  2. Meeting Abstract (28)
  3. Research Letter (3)
  4. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (71)
  2. Molecular Imaging and Therapy Service (71)
  3. Radiology, Department of (71)
  4. Department of Medicine (58)
  5. Survivorship Research (48)
  6. Solid Tumor Oncology Division (38)

More Groups

People
  1. Ahmet Dogan (23)
  2. Alison Moskowitz (17)
  3. Andrew Zelenetz (17)
  4. Anita Kumar (17)
  5. Paul Hamlin (17)
  6. Gilles Salles (16)

More People

Years
  1. 2025 (3)
  2. 2024 (10)
  3. 2023 (10)
  4. 2022 (3)
  5. 2021 (8)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Blood (8)
  3. European Journal of Nuclear Medicine and Molecular Imaging (6)
  4. International Journal of Radiation Oncology, Biology, Physics (5)
  5. Annals of Surgical Oncology (4)
  6. Hematological Oncology (3)

More Publications

Publishers
  1. Springer (15)
  2. American Society of Clinical Oncology (12)
  3. American Society of Hematology (10)
  4. Elsevier Inc. (6)
  5. Wiley Blackwell (5)
  6. Nature Publishing Group (3)

More Publishers

Results (71)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical, imaging, and technical factors associated with successful genomic profiling of bone biopsy tissue in prostate cancer
    Journal Article

    Ridouani, F.; Vargas, H. A.; Holzwanger, D. J.; Schöder, H.; Waters, E.; Petre, E. N.; Martin, A.; Satagopan, J.; Gonen, M.; Autio, K. A.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinoma
    Journal Article

    White, C.; Jayaprakasam, V. S.; Tenet, M.; Tang, L. H.; Schattner, M. A.; Janjigian, Y. Y.; Maron, S. B.; Schöder, H.; Larson, S. M.; Gönen, M.; more...
    European Journal of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • [(18)F]TFB PET/CT misses intense [(124)I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer
    Journal Article

    Backhaus, P.; Pentlow, K. S.; Ho, A. L.; Mauguen, A.; Fagin, J. A.; Pillarsetty, N. V. K.; Lyashchenko, S. K.; Burnazi, E.; Ghossein, R. A.; Chhabra, S.; more...
    EJNMMI Research (2024)

    Fulltext@MSK | Save
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • The combination of patient-specific tumor and HPV sequencing to enable high-sensitivity detection of ctDNA in patients with HPV-associated oropharyngeal carcinoma
    Meeting Abstract

    Diplas, B.; Brown, D. N.; Pei, X.; Chen, L.; Graybill, C.; Korn, W. M.; Westheimer, E.; Novaj, A.; Humm, J.; Shukla-Dave, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • (18)F-BMS-986229 PET to assess programmed-death ligand 1 status in gastroesophageal cancer
    Journal Article

    Cytryn, S. L.; Pandit-Taskar, N.; Lumish, M. A.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Antoine, A.; Loegel, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Patient metabolic profile defined by liver and muscle (18)F-FDG PET avidity is independently associated with overall survival in gastric cancer
    Journal Article

    Vitiello, G. A.; Jayaprakasam, V. S.; Tang, L. H.; Schattner, M. A.; Janjigian, Y. Y.; Ku, G. Y.; Maron, S. B.; Schoder, H.; Larson, S. M.; Gönen, M.; more...
    Gastric Cancer (2024)

    Fulltext@MSK | Save